Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

SnapshotDx Quiz: July 2019.

Oliver BU, Chu EY.

J Invest Dermatol. 2019 Jul;139(7):e71-e75. doi: 10.1016/j.jid.2019.05.004. Epub 2019 Jun 20. No abstract available.

PMID:
31679736
2.

SnapshotDx Quiz: November 2019.

Brown-Korsah JB, Chu EY.

J Invest Dermatol. 2019 Nov;139(11):e121-e126. doi: 10.1016/j.jid.2019.08.431. No abstract available.

PMID:
31648688
3.

Use of new molecular tests for melanoma by pigmented-lesion experts.

Varedi A, Gardner LJ, Kim CC, Chu EY, Ming ME, Leachman SA, Curiel-Lewandrowski C, Swetter SM, Grossman D.

J Am Acad Dermatol. 2019 Aug 13. pii: S0190-9622(19)32569-1. doi: 10.1016/j.jaad.2019.08.022. [Epub ahead of print] No abstract available.

PMID:
31415835
4.

Generalized congenital epithelioid blue nevi (pigmented epithelioid melanocytomas) in an infant: Report of case and review of the literature.

Blebea C, Li D, Castelo-Soccio L, Chu EY.

J Cutan Pathol. 2019 Dec;46(12):954-959. doi: 10.1111/cup.13544. Epub 2019 Jul 22.

PMID:
31283031
5.

Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.

Ma SA, O'Day CP, Dentchev T, Takeshita J, Ridky TW, Seykora JT, Chu EY.

J Cutan Pathol. 2019 May;46(5):310-316. doi: 10.1111/cup.13424. Epub 2019 Feb 14.

PMID:
30666677
6.

NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib.

Parekh V, Sobanko J, Miller CJ, Karakousis G, Xu W, Letrero R, Elenitsas R, Xu X, Elder DE, Amaravadi R, Schuchter LM, Nathanson KL, Wilson MA, Chu EY.

J Cutan Pathol. 2019 Mar;46(3):190-194. doi: 10.1111/cup.13401. Epub 2018 Dec 27.

PMID:
30552700
7.

The transcription factor AmeloD stimulates epithelial cell motility essential for tooth morphology.

Chiba Y, He B, Yoshizaki K, Rhodes C, Ishijima M, Bleck CKE, Stempinski E, Chu EY, Nakamura T, Iwamoto T, de Vega S, Saito K, Fukumoto S, Yamada Y.

J Biol Chem. 2019 Mar 8;294(10):3406-3418. doi: 10.1074/jbc.RA118.005298. Epub 2018 Nov 30.

PMID:
30504223
8.

A Blue-Gray Macule on the Back: Challenge.

Aderibigbe O, Groft-MacFarlane C, Chu EY.

Am J Dermatopathol. 2018 Oct 9. doi: 10.1097/DAD.0000000000001268. [Epub ahead of print] No abstract available.

PMID:
30308544
9.

Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.

Kim CC, Berry EG, Marchetti MA, Swetter SM, Lim G, Grossman D, Curiel-Lewandrowski C, Chu EY, Ming ME, Zhu K, Brahmbhatt M, Balakrishnan V, Davis MJ, Wolner Z, Fleming N, Ferris LK, Nguyen J, Trofymenko O, Liu Y, Chen SC; Pigmented Lesion Subcommittee, Melanoma Prevention Working Group.

JAMA Dermatol. 2018 Dec 1;154(12):1401-1408. doi: 10.1001/jamadermatol.2018.3359.

10.

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB.

Cancer. 2019 Jan 1;125(1):18-44. doi: 10.1002/cncr.31719. Epub 2018 Oct 3. Review. Erratum in: Cancer. 2019 Aug 1;125(15):2706.

PMID:
30281145
11.
12.

Timing of Onset of Adverse Cutaneous Reactions Associated With Programmed Cell Death Protein 1 Inhibitor Therapy.

Wang LL, Patel G, Chiesa-Fuxench ZC, McGettigan S, Schuchter L, Mitchell TC, Ming ME, Chu EY.

JAMA Dermatol. 2018 Sep 1;154(9):1057-1061. doi: 10.1001/jamadermatol.2018.1912.

13.

SnapshotDx Quiz: July 2018.

Berg SA, Chu EY.

J Invest Dermatol. 2018 Jul;138(7):e47. doi: 10.1016/j.jid.2018.05.004. No abstract available.

14.

Pembrolizumab-induced sarcoidal infusion site reaction.

Smith RJ, Mitchell TC, Chu EY.

J Cutan Pathol. 2018 Jun 25. doi: 10.1111/cup.13307. [Epub ahead of print] No abstract available.

PMID:
29938827
15.

Association of Marital Status With T Stage at Presentation and Management of Early-Stage Melanoma.

Sharon CE, Sinnamon AJ, Ming ME, Chu EY, Fraker DL, Karakousis GC.

JAMA Dermatol. 2018 May 1;154(5):574-580. doi: 10.1001/jamadermatol.2018.0233.

16.

Reduced Orthodontic Tooth Movement in Enpp1 Mutant Mice with Hypercementosis.

Wolf M, Ao M, Chavez MB, Kolli TN, Thumbigere-Math V, Becker K, Chu EY, Jäger A, Somerman MJ, Foster BL.

J Dent Res. 2018 Jul;97(8):937-945. doi: 10.1177/0022034518759295. Epub 2018 Mar 13.

17.

The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.

Sinnamon AJ, Sharon CE, Song Y, Neuwirth MG, Elder DE, Xu X, Chu EY, Ming ME, Fraker DL, Gimotty PA, Karakousis GC.

J Am Acad Dermatol. 2018 Aug;79(2):245-251. doi: 10.1016/j.jaad.2018.02.066. Epub 2018 Mar 5.

PMID:
29518458
18.

SnapshotDx Quiz: March 2018.

Gaddis K, Chu EY.

J Invest Dermatol. 2018 Mar;138(3):e31. doi: 10.1016/j.jid.2018.01.012. No abstract available.

19.

Impact of a smartphone application on skin self-examination rates in patients who are new to total body photography: A randomized controlled trial.

Marek AJ, Chu EY, Ming ME, Khan ZA, Kovarik CL.

J Am Acad Dermatol. 2018 Sep;79(3):564-567. doi: 10.1016/j.jaad.2018.02.025. Epub 2018 Feb 10. No abstract available.

20.

Osteopontin regulates dentin and alveolar bone development and mineralization.

Foster BL, Ao M, Salmon CR, Chavez MB, Kolli TN, Tran AB, Chu EY, Kantovitz KR, Yadav M, Narisawa S, Millán JL, Nociti FH Jr, Somerman MJ.

Bone. 2018 Feb;107:196-207. doi: 10.1016/j.bone.2017.12.004. Epub 2017 Dec 5.

21.

Hypercementosis Associated with ENPP1 Mutations and GACI.

Thumbigere-Math V, Alqadi A, Chalmers NI, Chavez MB, Chu EY, Collins MT, Ferreira CR, FitzGerald K, Gafni RI, Gahl WA, Hsu KS, Ramnitz MS, Somerman MJ, Ziegler SG, Foster BL.

J Dent Res. 2018 Apr;97(4):432-441. doi: 10.1177/0022034517744773. Epub 2017 Dec 15.

22.

Lupus-like cutaneous reaction following pembrolizumab: An immune-related adverse event associated with anti-PD-1 therapy.

Shao K, McGettigan S, Elenitsas R, Chu EY.

J Cutan Pathol. 2018 Jan;45(1):74-77. doi: 10.1111/cup.13059. Epub 2017 Nov 10.

PMID:
29028121
23.

Cutaneous Metastases of Melanoma Mimicking Interstitial Granulomatous Processes.

Parekh V, Miller CJ, Elenitsas R, Chu EY.

Am J Dermatopathol. 2018 Sep;40(9):706-707. doi: 10.1097/DAD.0000000000000996. No abstract available.

PMID:
28937441
24.

Reply to: "Statistical and methodological issues".

Shin TM, Shaikh WR, Etzkorn JR, Sobanko JF, Margolis DJ, Gelfand JM, Chu EY, Elenitsas R, Miller CJ.

J Am Acad Dermatol. 2017 Oct;77(4):e115-e116. doi: 10.1016/j.jaad.2017.05.030. No abstract available.

PMID:
28917479
25.

Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Ao M, Chavez MB, Chu EY, Hemstreet KC, Yin Y, Yadav MC, Millán JL, Fisher LW, Goldberg HA, Somerman MJ, Foster BL.

Bone. 2017 Dec;105:134-147. doi: 10.1016/j.bone.2017.08.027. Epub 2017 Sep 1.

26.

Development of RET mutant cutaneous angiosarcoma during BRAF inhibitor therapy.

Dai J, Kunder CA, Chu EY, Chan EF, Egan CL, Novoa RA.

J Cutan Pathol. 2017 Dec;44(12):1053-1056. doi: 10.1111/cup.13024. Epub 2017 Sep 13.

PMID:
28796396
27.

Disrupted IRF6-NME1/2 Complexes as a Cause of Cleft Lip/Palate.

Parada-Sanchez MT, Chu EY, Cox LL, Undurty SS, Standley JM, Murray JC, Cox TC.

J Dent Res. 2017 Oct;96(11):1330-1338. doi: 10.1177/0022034517723615. Epub 2017 Aug 2.

28.

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.

Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W 3rd, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK.

Melanoma Manag. 2017 Mar;4(1):13-37. doi: 10.2217/mmt-2016-0022. Epub 2017 Mar 1. Review.

29.

Association Between Patient Age and Lymph Node Positivity in Thin Melanoma.

Sinnamon AJ, Neuwirth MG, Yalamanchi P, Gimotty P, Elder DE, Xu X, Kelz RR, Roses RE, Chu EY, Ming ME, Fraker DL, Karakousis GC.

JAMA Dermatol. 2017 Sep 1;153(9):866-873. doi: 10.1001/jamadermatol.2017.2497.

30.

Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas.

Miller CJ, Shin TM, Sobanko JF, Sharkey JM, Grunyk JW, Elenitsas R, Chu EY, Capell BC, Ming ME, Etzkorn JR.

J Am Acad Dermatol. 2017 Aug;77(2):333-340.e1. doi: 10.1016/j.jaad.2017.03.025.

PMID:
28711085
31.

WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation.

Xu M, Horrell J, Snitow M, Cui J, Gochnauer H, Syrett CM, Kallish S, Seykora JT, Liu F, Gaillard D, Katz JP, Kaestner KH, Levin B, Mansfield C, Douglas JE, Cowart BJ, Tordoff M, Liu F, Zhu X, Barlow LA, Rubin AI, McGrath JA, Morrisey EE, Chu EY, Millar SE.

Nat Commun. 2017 Jun 7;8:15397. doi: 10.1038/ncomms15397.

32.

Complete Response of Advanced Melanoma Treated With Talimogene Laherparepvec and Subsequent Sweet's-like Infiltrate.

Parekh V, Gangadhar T, Kreider KL, Elenitsas R, Chu EY.

JAMA Dermatol. 2017 Jul 1;153(7):719-721. doi: 10.1001/jamadermatol.2017.0466. No abstract available.

PMID:
28445579
33.

Clinical and pathologic factors associated with subclinical spread of invasive melanoma.

Shin TM, Shaikh WR, Etzkorn JR, Sobanko JF, Margolis DJ, Gelfand JM, Chu EY, Elenitsas R, Miller CJ.

J Am Acad Dermatol. 2017 Apr;76(4):714-721. doi: 10.1016/j.jaad.2016.11.048. Epub 2017 Jan 28.

PMID:
28139264
34.

Clinical factors associated with subclinical spread of in situ melanoma.

Shin TM, Etzkorn JR, Sobanko JF, Margolis DJ, Gelfand JM, Chu EY, Elenitsas R, Shaikh WR, Miller CJ.

J Am Acad Dermatol. 2017 Apr;76(4):707-713. doi: 10.1016/j.jaad.2016.10.049. Epub 2017 Jan 7.

PMID:
28073583
35.

p15 Expression Differentiates Nevus from Melanoma.

Taylor LA, O'Day C, Dentchev T, Hood K, Chu EY, Ridky TW, Seykora JT.

Am J Pathol. 2016 Dec;186(12):3094-3099. doi: 10.1016/j.ajpath.2016.08.009. Epub 2016 Nov 14.

36.

Assessment of smartphone applications for total body digital photography-guided skin exams by patients.

Marek AJ, Chu EY, Ming ME, Kovarik CL.

J Am Acad Dermatol. 2016 Nov;75(5):1063-1064.e1. doi: 10.1016/j.jaad.2016.06.005. No abstract available.

37.

Full Spectrum of Postnatal Tooth Phenotypes in a Novel Irf6 Cleft Lip Model.

Chu EY, Tamasas B, Fong H, Foster BL, LaCourse MR, Tran AB, Martin JF, Schutte BC, Somerman MJ, Cox TC.

J Dent Res. 2016 Oct;95(11):1265-73. doi: 10.1177/0022034516656787. Epub 2016 Jul 1.

38.

Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.

Lott JP, Elmore JG, Zhao GA, Knezevich SR, Frederick PD, Reisch LM, Chu EY, Cook MG, Duncan LM, Elenitsas R, Gerami P, Landman G, Lowe L, Messina JL, Mihm MC, van den Oord JJ, Rabkin MS, Schmidt B, Shea CR, Yun SJ, Xu GX, Piepkorn MW, Elder DE, Barnhill RL; International Melanoma Pathology Study Group.

J Am Acad Dermatol. 2016 Aug;75(2):356-63. doi: 10.1016/j.jaad.2016.04.052. Epub 2016 May 14.

39.

Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma.

Mochel MC, Ming ME, Imadojemu S, Gangadhar TC, Schuchter LM, Elenitsas R, Payne AS, Chu EY.

J Cutan Pathol. 2016 Sep;43(9):787-91. doi: 10.1111/cup.12735. Epub 2016 Jun 1.

PMID:
27161449
40.

Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma.

Marek AJ, Ming ME, Bartlett EK, Karakousis GC, Chu EY.

JAMA Dermatol. 2016 Jul 1;152(7):836-7. doi: 10.1001/jamadermatol.2016.0875. No abstract available.

41.

Correlation Between Appropriate Use Criteria and the Frequency of Subclinical Spread or Reconstruction With a Flap or Graft for Melanomas Treated With Mohs Surgery With Melanoma Antigen Recognized by T Cells 1 Immunostaining.

Etzkorn JR, Sobanko JF, Shin TM, Elenitsas R, Chu EY, Gelfand JM, Margolis DJ, Newman JG, Goldbach H, Miller CJ.

Dermatol Surg. 2016 Apr;42(4):471-6. doi: 10.1097/DSS.0000000000000693.

42.

CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature.

Sargen MR, Merrill SL, Chu EY, Nathanson KL.

Br J Dermatol. 2016 Oct;175(4):785-9. doi: 10.1111/bjd.14485. Epub 2016 Jun 8. Review.

PMID:
26876133
43.

Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individuals.

Feldmeyer L, Ching G, Vin H, Ma W, Bansal V, Chitsazzadeh V, Jahan-Tigh R, Chu EY, Fuller P, Maiti S, Davis RE, Cooper LJ, Tsai KY.

Exp Dermatol. 2016 Mar;25(3):245-7. doi: 10.1111/exd.12878. Epub 2015 Nov 23. No abstract available.

PMID:
26475987
44.

Sorafenib-Induced Eruption Mimicking Erythema Multiforme.

Pichard DC, Cardones AR, Chu EY, Dahut WL, Kong HH.

JAMA Dermatol. 2016 Feb;152(2):227-8. doi: 10.1001/jamadermatol.2015.2930. No abstract available.

45.
46.

Routine nail clipping leads to the diagnosis of amelanotic nail unit melanoma in a young construction worker.

Boni A, Chu EY, Rubin AI.

J Cutan Pathol. 2015 Aug;42(8):505-9. doi: 10.1111/cup.12558. No abstract available.

PMID:
26272255
47.

Presentation of Acute Megakaryoblastic Leukemia Associated with a GATA-1 Mutation Mimicking the Eruption of Transient Myeloproliferative Disorder.

Boos MD, Wine Lee L, Freedman JL, Novoa RA, Chu EY, Perman MJ.

Pediatr Dermatol. 2015 Sep-Oct;32(5):e204-7. doi: 10.1111/pde.12643. Epub 2015 Jul 23.

PMID:
26205501
48.

Rare angioinvasive fungal infection in association with leukemia cutis.

Chang YC, Stewart C, Chu EY, Rosenbach M.

Cutis. 2015 Jun;95(6):332-5.

PMID:
26125209
49.

Photo-distributed lichenoid eruption secondary to direct anti-viral therapy for hepatitis C.

Simpson CL, McCausland D, Chu EY.

J Cutan Pathol. 2015 Oct;42(10):769-73. doi: 10.1111/cup.12532. Epub 2015 Jul 3.

PMID:
25974215
50.

The histopathologic features of Integra® Dermal Regeneration Template.

Lee SM, Stewart CL, Miller CJ, Chu EY.

J Cutan Pathol. 2015 May;42(5):368-9. doi: 10.1111/cup.12488. Epub 2015 Apr 27. No abstract available.

PMID:
25759974

Supplemental Content

Support Center